Background: In patients with diabetes mellitus type 2 and arterial hypertension, the control of
systolic and diastolic blood pressure is essential to reduce the risk of adverse events. The …

Background: Effective blood pressure (BP)-lowering therapy is regarded as the most
important intervention in diabetes mellitus. Nebivolol is commonly used for the treatment of …

Background Nebivolol represents a therapeutic class of beta blockers with high beta 1
selectivity and modulatory effect on vascular reactions by releasing nitric oxide (NO) from …

Background and Objectives: Hypertension is a widely prevalent con-dition of elevated blood
pressure (BP) and is the leading risk factor for the development of cardiovascular disease …

Background Nebivolol represents a new therapeutic class of beta blockers with high beta1
selectivity and the ability to modu late the direct vascular reactions through the liberation of …

CONTEXT AND OBJECTIVES: Assessment of central blood pressure (BP) has grown
substantially over recent years because evidence has shown that central BP is more …

2. Results During nebivolol treatment, significant (p< 0.000 I) decreases occurred in systolic
and diastolic blood pressure and heart rate. In the supine position, systolic blood pressure …

Objectives: Nebivolol is a lipophilic beta-blocker without sympathomimetic activity, but with
apparently nitric oxide-mediated vasodilating effects. Previous studies have shown that …

Background: Nebivolol is a third-generation β-blocker, with highest β 1 selectivity and nitric-
oxide-derived vasodilatation. It also exhibits antiproliferative and antioxidant property that …

Objectives: To study the effect of nebivolol 5 mg once daily versus (S)-atenolol 25 mg once
daily in patients with essential hypertension. Materials and Methods: A prospective study …